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Claus Rath*, Martin Andreas, Caesar Khazen, Dominik Wiedemann, Andreas Habertheuer and Alfred KocherAbstract
Pacemaker lead malpositioning may lead to severe clinical adverse events. Rarely, cases of inadvertent placement of
a lead into the left ventricle are reported in the literature. We herein report a case of pacemaker lead malpositioning
into the left ventricle via a persistent foramen ovale in a male caucasian patient. After this procedural adverse event, the
patient suffered from two ischemic strokes despite antiplatelet and anticoagulation therapy.
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While unidentified malpositioning of a pacemaker lead
is already a rare complication at all, only a few cases of
inadvertently placement of a lead into the left ventricle
are reported in the literature. Neither incidence, nor
clinical history of this complication are well known.
Malpositioning of a lead may cause structural dam-
age or trigger thromboembolic events. Although lead
repositioning is the treatment of choice, there are no
data about procedurals risks, neither are there distinct
recommendations to improve safety of these high-risk
interventions.Case presentation
A 75-year-old, male, caucasian patient was admitted to
the neurology department of a peripheral hospital due to
an ischemic stroke in the supply area of the left posterior
cerebral artery.
Patient’s history revealed type 2 diabetes mellitus and
coronary heart disease with previous NSTEMI and sub-
sequent stenting. Furthermore, a prior thrombosis in
the popliteal vein was reported. Current medication was
50 mg acetylsalicylic acid, an angiotensin-converting-
enzyme inhibitor, hydrochlorothiazide and metformin.
The patient underwent implantation of a permanent* Correspondence: claus.rath@meduniwien.ac.at
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reproduction in any medium, provided the ordual chamber pacemaker (Medtronic Ensura EN1DR01
MR) one month before admission due to a Sick-Sinus-
Syndrome.
The patient was primarily loaded with 325 mg acetyl-
salicylic acid and low-molecular-weight heparin. The
oral diabetes medication was stopped. Since the stroke
occurred under the therapy with acetylsalicylic acid, it
was replaced by clopidogrel (75 mg per day). Additionally,
low-molecular-weight heparin (LMWH) in therapeutic
dose was prescribed. The pacemaker control showed in-
conspicuous parameters. The pacing thresholds, the im-
pedance of the electrodes and the sensing were normal. A
self-limiting episode supraventricular tachycardia was re-
corded, another episode occurred during the control. Diag-
nostic assessment of cardiac risk factors was done. A chest
X-ray gave a first hint for a problem with the ventricular
lead, since it was deflected and followed an unusual course
(Figure 1). Transesophageal echocardiography revealed a
patent foramen ovale (PFO) with a diameter of 8 mm and
malpositioning of the ventricular pacemaker lead. This lead
was unintentionally malpositioned via the PFO into the left
ventricle. The atrial lead was correctly placed at the bottom
of the right atrium (Figure 2). Echocardiography didn’t re-
veal any thrombotic material on the ventricular lead.
While still being hospitalised, twenty-two days after
the admission and eighteen days after detection of the
lead malpositioning, the patient suffered of another is-
chemic stroke - located in the supply area of the right
posterior cerebral artery and in the left cerebellar region.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Chest X-ray. The ventricular pacemaker lead follows an
unusual course (black arrows) due to its placement via a PFO into
the left ventricle.
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partment for re-positioning of the ventricular lead and
closure of the PFO.
In a first session, in general anaesthesia, using a percu-
taneous approach, the lead was retracted and repositionedFigure 2 a and b: Transoesophageal echocardiography
revealed a PFO. LV left ventricle; RV right ventricle; * PFO,
8 mm; ** pacemaker lead; *** contrast agent.into the right ventricle. A few days later, the PFO was
closed with a 25 mm Amplatzer® Septal Occluder in a sec-
ond session (Figure 3). After an uneventful postoperative
course, the patient was transferred to a peripheral hospital
for neurorehabilitation.
Conclusion
Though pacemaker implantation is a common proced-
ure, the complication rates associated with pacemaker
implantation vary between 1.7% [1] and 12.4% [2] ac-
cording to recent studies. Up-to-date data regarding
pacing-lead induced thrombotic and thromboembolic
events in general population are not available. Data from
the 1970s and 1980s suggest an event rate from 0.6% to
3.5% [3-7]. In patients with intracardiac shunts, event
rates from 0.5% to 0.7% per year were identified. In pa-
tients with intracardiac shunts and transvenous pacing,
risk for systemic thromboemboli is twice as high. For this
group of patients, neither for aspirin nor for warfarin a
positive effect could be demonstrated [8].
To our best knowledge, the presented case is the first
one in the literature, where a misplaced pacing lead into
the left ventricle led to ischemic strokes in a patient with
both, prophylactic anticoagulation and antiplatelet ther-
apy. At the time the patient suffered of the second
stroke, his coagulation parameters were within a normal
range. The creatinine levels remained throughout the
stay between 0,97 mg/dl and 1.16 mg/dl. However, we
cannot completely exclude the possibility of undertreat-
ment with LMWH. Furthermore, paroxysmal atrial fib-
rillation might also be a reason for the recurrent stroke,
although AF had not been reported in the patient’s med-
ical history and the ECG did not show any signs of AF.
In permanent pacemaker implantation, some manoeu-
vres may increase the secure lead placement in the right
ventricle. First, the lead should be introduced with a
loop through the tricuspid valve and not directly with
the tip to avoid placement in the coronary sinus. Further,
the occurrence of ventricular extrasystoles is a good in-
dicator for being in the ventricle. Then, the lead could
be advanced with the tip into the pulmonary outflow
tract or pulmonary artery to confirm the correct pos-
ition. Thereafter, the lead is pulled back and advanced
into the apex of the right ventricle. If the lead measure-
ments are not in the recommended range, lead place-
ment should be repeated.
Two view chest-X-ray and an ECG should be per-
formed routinely after pacemaker implantation.
Even if the electrode seems to be in the correct position
on the frontal radiograph, the lateral view may reveal a
malposition of an electrode.
If the ventricular lead was placed correctly into the right
ventricle, one would expect a left bundle branch block pat-
tern when taking a 12-lead ECG (electrocardiogram). A
Figure 3 a and b: Chest fluoroscopy. A few days after the re-positioning of the ventricular lead, the PFO was closed with a 25 mm Amplatzer®
Septal Occluder.
Figure 4 a and b: ECGs before and after repositioning of the ventricular pacemaker lead did not show any signs for pacemaker lead malpositioning.
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about the placement of the lead. This should be controlled
after every implantation, which may not always be the
case.
In our patient, the ECG did not show any alarming ab-
normalities after the initial pacemaker implantation. It
was classified as Sinus rhythm at 76 bpm with left axis
deviation. PQ-interval, QRS complex, ST-segment and
QT-interval were within a normal range. A left anterior
fascicular block was diagnosed. Myocardial ischemia of
the posterior wall was known from the patient’s medical
history (Figure 4a). After repositioning of the lead, the
ECG was interpreted as Sinus rhythm at 95 bpm with
left axis deviation, left anterior hemi block and repolari-
sation disorder (Figure 4b).
A few cases have been reported, where patients didn’t
suffer of any thromboembolic events despite a pacing
lead placed into the left ventricle via a PFO [9-11].
However, the thrombogenic potential of pacemaker
leads may be underestimated in clinical routine, espe-
cially in patients with intracardial shunting and pre-
existing myocardial damage.
This case underlines the urgent surgical revision of
misplaced pacemaker leads. It highlights the importance
of echocardiography for post-surgical control in difficult
patients or in patients with signs of lead malpositioning.
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